The Role of Human-Centered Design in Insulin Pen Innovation and the Future of Insulin Delivery.
design research
design thinking
diabetes
human-centered design
insulin pens
Journal
Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
pubmed:
7
9
2021
medline:
3
6
2022
entrez:
6
9
2021
Statut:
ppublish
Résumé
Insulin pens have made a dramatic impact on diabetes care, with evidence suggesting that they promote performance of self-care and reduce negative health outcomes for people with diabetes. Human-centered design (HCD), practiced by IDEO for over 40 years and together with Eli Lilly for over 15 years, has helped to design insulin pens that evolved with the needs of people with diabetes. HCD employs unique methods that help to uncover people's needs and design with them in mind. The future of diabetes care is bright with the ongoing application of HCD methodology in this space.
Identifiants
pubmed: 34486416
doi: 10.1177/19322968211043921
pmc: PMC9294580
doi:
Substances chimiques
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
623-627Références
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Diabetes Care. 1999 Jan;22(1):137-40
pubmed: 10333915
Pharmacotherapy. 2007 Jul;27(7):948-62
pubmed: 17594200
J Diabetes Sci Technol. 2010 May 01;4(3):505-13
pubmed: 20513314
Diabetes Spectr. 2019 Nov;32(4):378-384
pubmed: 31798296
Diabetes Ther. 2020 Jun;11(6):1251-1269
pubmed: 32410184
Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1
pubmed: 17157128
Clin Ther. 2003 Nov;25(11):2836-48
pubmed: 14693308
J Diabetes Sci Technol. 2018 May;12(3):551-553
pubmed: 29411641
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Clin Ther. 2007 Jun;29(6 Pt 1):1294-305
pubmed: 18036391